• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Tekmira Pharmaceuticals Corp (TKMR)

    -NasdaqCM
    13.65 Down 0.24(1.73%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:13.89
    Open:13.79
    Bid:12.50 x 500
    Ask:N/A
    1y Target Est:28.00
    Beta:-0.76
    Earnings Date:Aug 11 - Aug 17 (Est.)
    Day's Range:13.45 - 14.01
    52wk Range:8.86 - 29.93
    Volume:685,833
    Avg Vol (3m):762,997
    Market Cap:740.16M
    P/E (ttm):N/A
    EPS (ttm):-1.36
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TKMR

    Comparison

    Symbol% ChgMkt Cap
    TKMRDown 1.73%740.16M
    MRNA 0.00%N/A
    RXIIUp 0.99%15.61M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):49.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.41
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback